WO1992009181A1 - Contact transducer assembly for hearing devices - Google Patents
Contact transducer assembly for hearing devices Download PDFInfo
- Publication number
- WO1992009181A1 WO1992009181A1 PCT/US1991/008333 US9108333W WO9209181A1 WO 1992009181 A1 WO1992009181 A1 WO 1992009181A1 US 9108333 W US9108333 W US 9108333W WO 9209181 A1 WO9209181 A1 WO 9209181A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- contact
- tympanic membrane
- transducer
- transducer assembly
- support means
- Prior art date
Links
Classifications
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R25/00—Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception
- H04R25/60—Mounting or interconnection of hearing aid parts, e.g. inside tips, housings or to ossicles
- H04R25/604—Mounting or interconnection of hearing aid parts, e.g. inside tips, housings or to ossicles of acoustic or vibrational transducers
- H04R25/606—Mounting or interconnection of hearing aid parts, e.g. inside tips, housings or to ossicles of acoustic or vibrational transducers acting directly on the eardrum, the ossicles or the skull, e.g. mastoid, tooth, maxillary or mandibular bone, or mechanically stimulating the cochlea, e.g. at the oval window
Definitions
- the present invention relates to hearing systems and, in particular, to hearing systems that enable or enhance an individual's ability to hear by imparting vibrations to the tympanic membrane.
- acoustic transducers that produce amplified sound waves which, in turn, impart vibrations to the tympanic membrane or eardrum.
- the telephone earpiece, radio, television and aids for the hearing impaired are all examples of systems that employ acoustic drive mechanisms.
- the telephone earpiece for instance, converts signals transmitted on a wire into vibrational energy in a speaker which, in turn, vibrates the tympanic membrane. These vibrations, at varying frequencies and amplitudes, result in the perception of sound by a person with normal hearing.
- Hearing systems that deliver audio information to the ear through electromagnetic transducers are well known. These transducers convert electromagnetic fields, modulated to contain audio information, into vibrations which are imparted to the tympanic membrane or parts of the middle ear.
- the transducer typically a magnet, is subjected to displacement by electromagnetic fields to impart vibrational motion to the portion to which it is attached, thus producing sound perception by the wearer of such an electromagnetically driven system.
- This method of sound perception possesses some advantages over acoustic drive systems in terms of quality, efficiency, and most importantly, elimination of "feedback, " a problem common to acoustic hearing systems.
- Feedback in acoustic hearing systems occurs when a portion of the acoustic output energy returns or "feeds back" to the input transducer (microphone), thus causing self-sustained oscillation.
- the potential for feedback is generally proportional to the amplification level of the system and, therefore, the output level of many acoustic drive systems has to be reduced to less than a desirable level to prevent a feedback situation.
- This problem which results in output inadequate to compensate for hearing losses in particularly severe cases, continues to be a major problem with acoustic type hearing aids.
- Electromagnetic hearing systems on the other hand, rely on electromagnetic energy output and therefore, the potential for feedback is essentially eliminated (Bojrab, 1988).
- a more general object of the current invention is to provide an improved hearing system which is unobtrusive and which has elements which are easily taken on and off of a user.
- the present invention discloses a system and method which employs a device for producing electromagnetic signals containing audio information, and a contact transducer assembly which is weakly but sufficiently, and removably, affixed to the tympanic membrane of the wearer by surface adhesion.
- the contact transducer assembly of the present invention comprises a transducer which is responsive to electromagnetic signals to produce vibrations that represent the audio information.
- the transducer is supported, at least in part, by a biocompatible structure having a contact surface with a surface area and configuration sufficient to support the transducer at a desired location on the tympanic membrane, and in vibrationally coupled relationship to the tympanic membrane.
- the present invention thus enables the wearer of the contact transducer assembly to conveniently and facilely install or remove the assembly when the particular application has ended, or for routine cleaning, maintenance, etc.
- the installation and removal of the contact transducer assembly is much like the method for insertion and removal of conventional contact lenses for the eyes.
- Figure 1 is a schematic top view of the contact transducer assembly according to one embodiment of the present invention showing the placement of the- contact transducer means in relation to the support means, and the location of the device on tympanic membrane of the wearer;
- FIGS. 2A through 2F are several schematic side and cross-sectional views for different embodiments of the present invention.
- Figure 3 shows a cut-away view of one contact transducer assembly of the present invention and a cut-away view of the umbo region of the tympanic membrane showing the approximate location of the device on the tympanic membrane of the wearer in one embodiment of the present invention
- Figure 4 is a schematic diagram showing the approximate placement of the contact transducer assembly on the tympanic membrane in one embodiment of the current invention, and the relationship of the tympanic membrane at the end of the ear canal to the outer ear of the individual.
- a biocompatible material is one that is non-toxic, and is neither rejected by nor degrades biological tissue to which it is proximate or with which it is in contact.
- a "custom membrane” is a layer of a biocompatible material that supports the contact transducer assembly against the tympanic membrane, at least a portion of the layer substantially conforming to the surface topography of a corresponding portion of the tympanic membrane.
- a custom membrane is fabricated by making a negative impression of an individual's tympanic membrane, casting a positive mold of the negative impression, and then applying a layer of biocompatible material to the positive mold that will substantially match the surface topography of the tympanic membrane.
- Adhesive the word being used as a noun, is intended. to mean a substance which effects adhesive bonding between two adjacent surfaces. Adhesive bonding can occur in either of two ways: (1) by chemical forces at the interface between the adhesive and the two surfaces being joined; or, (2) by mechanical adhesion that involves an interlocking action at the molecular level between the adhesive and the materials being joined.
- surface adhesion means weak molecular attraction or mechanical interlocking between two surfaces of respective items without the use of an intermediate adhesive.
- the items joined are relatively inert, non-reactive, and retain their initial physical properties. Slight pressure and/or a wetting agent may be utilized to facilitate surface adhesion.
- non-reactive means a material whose chemical and physical state does not change in time, such as through evaporation of some component or through chemical cross-linking, such that the material is either unstable or loses its ability to function properly.
- vibrationally coupled means mutually engaged elements wherein substantially all vibrations produced in one element are imparted to the other causing the other to vibrate correspondingly.
- a "high energy permanent magnet” includes rare earth permanent magnets, or magnets of other materials which have a similar interactive response to variations in magnetic fields.
- impermanent attachment signifies a method that uses surface adhesion to weakly but sufficiently support a contact transducer assembly against the tympanic membrane of an individual according to the teaching of the current invention, without having to use surgical techniques or reactive adhesives.
- “manually releasable” means impermanent attachment wherein the weak but sufficient forces of surface adhesion may be easily overcome by manual manipulation of the transducer assembly without damage to the tympanic membrane or discomfort to the wearer.
- a "surface wetting agent” is a substance that enhance the ability of a surface to form a weak, but sufficient, attachment to another surface through surface adhesion.
- Surfaces can be roughly divided into two categories: hydrophobic (water-hating) and hydrophilic (water-loving).
- a surface wetting agent is a material that has similar surface characteristics, either its hydrophobicity or hydrophilicity, to the adjacent surface. Because of their similarities, a surface wetting agent will spread on the surface in question and form a thin film which, in turn can become a vehicle of adhesion to another surface. A wetting agent can therefore promote the adhesion between two surfaces.
- the adhesion between the non-reactive, pre-formed contact transducer assembly and the non-reactive tympanic membrane may be enhanced by the use of surface wetting agents.
- the surface wetting agent When a surface wetting agent is used, the surface wetting agent forms a thin film through strong attractive forces and enhances the natural surface adhesion phenomenon between surfaces.
- the purpose for using surface wetting agents with the contact transducer assembly of the current invention is analogous to the use of wetting solutions for contact lens applications.
- a "transducer” may comprise a magnet or magnetic particles dispersed throughout a membrane or attached structure, a coil or multiple coils, piezoelectric elements, passive or active electronic components in discrete, integrated, or hybrid form, or any singular component or combination of components that will impart vibrational motion to the tympanic membrane in response to appropriately received signals or any other means suitable for converting modulated electromagnetic waves to vibrations.
- the "umbo area” is the conical depression at the center of the tympanic membrane where it attaches to the inferior end of the malleus.
- unaided hearing means hearing without the use of an electromagnetic drive system.
- weakly but sufficiently and “weak but sufficient” both describe the qualities of the surface adhesion attachment forces with which a contact transducer assembly of the current invention is supported on a portion on the eardrum.
- An object that is weakly but sufficiently attached will remain situated in place during use without shaking loose when vibrated or when the individual wearing the device is jarred or moves about. The normal activity of the individual wearer of the device will not easily dislodge the assembly, yet the assembly can be facilely installed or removed manually. Weak but sufficient forces hold the assembly in place in the presence of vibrations and without the need for adhesives, and may be overcome by manual manipulation without damage to the tympanic membrane or discomfort to the user.
- the hearing system of the current invention comprises a signal producing means for producing electromagnetic signals that contain audio information, and a tympanic membrane contact transducer assembly which receives said signals and imparts vibrations to the ear.
- Said signal producing means and said contact transducer assembly will be described in greater detail with reference to the accompanying Figures. It should be noted that like numerals are employed to designate like parts throughout the Figures.
- Figure 1 depicts a top view of contact transducer assembly 98 of the present invention, which is further comprised of transducer means 100, and support means 102.
- Support means 102 is generally circular as viewed in Figure 1 and is attached to transducer means 100 on one surface (the top surface in Figure 1) of support means 102.
- Support means 102 is then attached to a portion of the tympanic membrane 106 at the opposite surface (the undersurface in Figure 1) of support means 102.
- the second surface of support means 102 that is attached to the tympanic membrane substantially conforms to the shape of the corresponding surface of the tympanic membrane, particularly the umbo area 104.
- transducer means 100 is substantially tapered, such as a conically frusto-conical pyramidally shaped magnet, as further described below.
- the smaller base is positioned toward the eardrum so that it fits within the depression in the umbo area.
- transducer means 100 may also be cylindrical rectangular or pillow-shaped. Other shapes for transducer means 100 are also possible and will be readily apparent to those skilled in the pertinent art.
- Figure 1 also shows transducer means 100 substantially centrally located on support means 102 according to the preferred embodiment of the current invention.
- the undersurface of support means 102 has a surface area and configuration sufficient to support transducer means 100 by manually releasable surface adhesion on the tympanic membrane.
- support means 102 is circular in the preferred embodiment of the current invention, support means 102 may take on any of a variety of alternate shapes, as will be readily apparent to thos skilled in the pertinent art.
- support means 102 has a larger diameter than transducer means 100.
- the outer dimension(s) of support means 102 may more closely approximate the outer dimension(s) of transducer means 100.
- the degree of surface adhesion required to weakly attach contact transducer assembly 98 to the tympanic membrane is a factor in determining the surface area and therefore the optimal size for support means 102.
- Contact transducer means 98 is shown on a portion of tympanic membrane 106 in Figure 1. In the preferred embodiment of the current invention, contact transducer means 98 is positioned against umbo area 104.
- transducer means 100 comprises a magnet 2 and, in particular, a permanent magnet.
- Said permanent magnet may further comprise a high energy rare earth magnet such as samarium-cobalt, neodymium- iron-boron, or any other high energy permanent magnet material as appropriate.
- transducer means 100 may comprise magnetic particles dispersed throughout a membrane or other structural portion of the support means 102.
- transducer 2 may comprise a coil or multiple coils, piezoelectric elements, passive or active electronic components in discrete, integrated, or hybrid form, or any singular component or combination of components that will impart vibrational motion to the tympanic membrane in response to appropriately received signals or any other means suitable for converting signals means to vibrations.
- Such variables are possible, conceivable, and are within the contemplated description of the contact transducer assembly according to the present invention.
- FIGS 2A through 2F show cross-sections of transducer means 100 and support means 102 of contact transducer assembly 98.
- Figure 2A shows one embodiment of the current invention in which transducer means 100 is comprised of a frusto-conical magnet 2, and wherein the support means 102 includes a housing 4.
- the housing 4 includes two layers 5 of biocompatible material.
- frusto-conically shaped magnet 2 is completely enclosed within the layers 5 of biocompatible material.
- the layers 5 may be comprised of the same or different materials, and each layer may be further comprised of a composite of materials or a plurality of layers.
- the outer one of layers 5 is additionally attached to membrane or interface 6 at a surface opposite that of the tympanic membrane.
- the purpose for housing 4 is to impart protection to the transducer from the physiological environment of the wearer, which includes air, water and salts, or other substances in close proximity to the ear canal of an individual with which magnet 2 could potentially react. Housing 4 therefore helps to ensure greater durability and longevity of magnet 2.
- Housing 4 also functions to prevent any biological degradation of the tissue surrounding transducer means 100. In instances where transducer means 100 is perceived as an irritant or is otherwise invasive to the body, or in those situations where the material of which transducer means 100 is comprised is not fully biocompatible, the biocompatible material of housing 4 ensures that transducer means 100 will be capable of being worn by the individual without discomfort or deleterious side effects. Alternately, in further embodiments consistent with the teaching of the current invention, transducer means 100 does not include a housing 4. Moreover, the housing 4 may be comprised of a plurality of layers 5 of biocompatible material, two examples of which are illustrated at Figures 2C and 2E.
- Figure 2A also shows support means 102 of contact transducer assembly 98 supported against the umbo area 104 of tympanic membrane 106.
- the interface 6 has a contact surface 7 which engages the tympanic membrane 106.
- the area and configuration and material for the surface of is selected so that surface adhesion, either inherent or with the aid of a surface wetting agent, attaches support means 102 weakly but sufficiently to tympanic membrane 106. Further discussion of surface wetting agents will be found below.
- Interface layer 6 of support means 102 may be comprised of a plurality of layers, depending upon the fabrication, use, etc. , of the particular prosthesis.
- FIG 2B shows an alternate embodiment of the prosthesis of the current invention, in which transducer means 100 is comprised of a magnet 2 and a single layer biocompatible housing 4.
- housing 4 completely encapsulates the frusto- conically shaped magnet 2.
- Sufficient provision for attachment of the housing 4 to the interface or membrane of the support means 102 is provided in the embodiment of the current invention depicted in Figure 2B by a lip 12 of interface 6.
- the embodiment of Figure 2B is supported directly by surface adhesion at the contact surface 7 of interface 6.
- the contact surface 7 of interface 6 conforms to the shape of tympanic membrane 106 at the umbo region 104.
- interface 6 may be comprised of a custom membrane.
- a custom membrane a negative impression of the eardrum of an individual is first made, for example as described below.
- a positive mold is then created, and a biocompatible material is then cast or molded from the positive impression to create a biocompatible interface 6 for support means 102 that ultimately attaches to the eardrum of the individual.
- Other custom molding or casting techniques may also be suitable.
- a non-custom interface may also be produced using a suitable material which is non-reactive but malleable to conform with the surface of the eardrum.
- a non-custom contact transducer assembly may be manufactured be determining a base shape or set of base shapes that will fit most tympanic membranes.
- the shape of a large number of eardrum may be determined in accordance with the techniques described in Decraemer, et ah, 1991. Standard mathematical clustering techniques such as those used by contact lens manufacturers, may then be used to classify shapes according to their similitude. One or more shapes may then be selected, by trial and error or by measurement of portions of the eardrum, such as the depth of the umbo depression, the angle of the manubrium, and the diameter of the eardrum,
- FIG. 2C An illustration of a prosthesis of the current invention with a custom membrane is shown in Figure 2C.
- the magnet 2 is covered by a biocompatible housing 4, and biocompatible layer 10.
- biocompatible housing 4 According to the embodiment of the current invention shown in Figure 2C, frusto-conically shaped magnet 2 is completely surrounded by the biocompatible housing 4, which in turn is attached to the outer surface of the interface 6.
- Biocompatible layer 10 partially encloses biocompatible housing 4, and further attaches to the outer surface of interface 6.
- a thin layer of surface wetting agent 14 is provided on the contact surface 7 of biocompatible interface 6 disposed against and conforming to the shape of tympanic membrane 106 at the contact surface 7.
- Surface wetting agent 14 is used to enhance the ability of support means 102 to form a weak but sufficient attachment to the tympanic membrane 106 through surface adhesion.
- surface wetting agent 14 is comprised of a non-reactive material, unlike glue or epoxy, which are hardening reactive adhesives. Surface wetting agents have relatively high intermolecular attractive forces with the adjacent surfaces if they have similar characteristics, e.g., hydrophobic or hydrophilic.
- surface wetting agent 14 The function of surface wetting agent 14 is to provide enhanced capability for contact transducer assembly 98 to form a sufficient, but weak adhesion to the tympanic membrane.
- Mineral oil has been used successfully as a surface welting agent, and as a spray periodically used after placement of the device.
- Figure 2D illustrates the placement of contact transducer assembly 98 against the tympanic membrane without the use of a surface wetting agent.
- magnet 2 in Figure 2F is attached directly to biocompatible interface 6 of support means 102, and housing 4 only partially encapsulates magnet 2.
- magnet 2 is shown frusto-conically shaped according to the preferred embodiment of the current invention. Additionally, magnet 2 is attached directly to a portion of a first surface of biocompatible interface
- Housing 4 only partially encapsulates magnet 2 and attaches to interface 6 along that portion of the first surface to which magnet 2 is not attached.
- support means 102 includes biocompatible interface 6 which conforms to, and is supported against, tympanic membrane 106 at a surface 7 opposing magnet 2.
- Interface 6 matches the curvature of tympanic membrane 106 at umbo area 104.
- FIG. 2E likewise shows the current invention with the additional feature of a positioning means.
- positioning means 16 is attached to magnet 2 at a first surface 15 of the magnet.
- positioning means 16 is located asymmetrically along first surface 15 of magnet 2.
- Support means 102 is attached directly to the magnet 2 along a surface thereof opposite surface 15.
- support means 102 includes a layer 9 which partially encloses the magnet 2 at lip 12.
- the layer 9 is attached to the interface or membrane 6.
- the shape of biocompatible interface 6 conforms to that of the tympanic membrane 106 at the umbo.
- Positioning means 16 may be useful for achieving proper alignment of the prosthesis on the tympanic membrane. Positioning means may also be used for engaging a self-insertion instrument. Such instrument may be used for insertion or removal of contact transducer assembly 98 in further embodiments of the current invention. Although depicted in Figure 2E as protruding from a surface 15 of magnet 2 according to the preferred embodiment of the current invention, positioning means 16 may also comprise such modifications as a notch or a raised section either on a third surface of the magnet 2 not in contact with the support means 102 or disposed opposite to support means 102.
- FIG 2F illustrates an embodiment wherein the magnet 2 is composed of a plurality of magnetic particles molded into and distributed throughout the membrane 6 of the support means 102.
- Figure 3 shows a simplified illustration of contact transducer assembly prosthesis 98 and its approximate placement on umbo area 104 of tympanic membrane 106 according to the preferred embodiment of the current invention.
- Transducer means 100 is attached to a first surface of support means 102, which likewise is positioned against tympanic membrane 106 at a second or contact surface opposite to that of transducer means 100.
- a partial cut-away view of support means 102 (showing biocompatible interface 6) and transducer means 100 are shown supported against cut-away portion 110 of tympanic membrane 106.
- Figure 3 also depicts a portion of ear canal 112, which ends at, and is separated from the middle ear by, tympanic membrane 106.
- malleus 114 against the opposite side of tympanic membrane 106 and part of the middle ear is malleus 114, to which is likewise attached incus 116.
- Malleus 114 and incus 116 are shown relative to tympanic membrane 106 in order to indicate relative location to ear canal 112 and the tilt of tympanic membrane 106 with the prosthesis of the current invention attached.
- Figure 4 depicts a larger cross-section of outer ear 124, middle ear
- contact transducer assembly 98 is positioned against tympanic membrane 106 at umbo area 104.
- the placement of contact transducer assembly 98 is also shown relative to the locations of malleus 114, incus 116, and stapes 118 of inner ear 122.
- Inner ear 122 is likewise adjacent to middle ear 120.
- a hearing system comprises signal producing means 130 for producing signals that contain audio information, and a contact transducer assembly which receives said signals and imparts audio information to an. individual.
- the information that signal producing means 130 transmits is in the form of electromagnetic energy
- transducer means 100 comprises a permanent magnet.
- electromagnetic signals impinging upon said permanent magnet cause said magnet to vibrate.
- transducer means 100 is vibrationally coupled to tympanic membrane 106, mechanical vibrations at transducer means 100 cause the individual wearer to perceive the vibrational energy in the form of sound.
- the signal producing means may comprise any suitable device operating in accordance with known principles to produce an electromagnetic field modulated to contain audio information.
- Such audio information can be captured by a microphone, as in a conventional acoustic hearing aid, or may be captured by other means such as an FM receiver.
- the electromagnetic field may, for example, be generated by passing electrical current signals modulated to contain audio information through a coil.
- signal producing means 130 may be used to receive radio frequency (RF) signals or ultrasound energy.
- RF radio frequency
- signal producing means 130 is located at a particular position within ear canal 112. However, signal producing means 130 may also be placed at different locations within ear canal 112. In still other embodiments of the current invention, signal producing means 130 may also be placed external to the ear canal.
- a contact transducer assembly was manufactured by the following procedures. A medical doctor took a negative impression of the eardrum of a patient following the protocol set out in Appendix A attached hereto. A positive mold was then prepared from the negative impression using a room temperature curing acrylic polymer comprised of audacryl RTC and methyl methacrylate using techniques as described in Appendix A. The resulting positive acrylic polymer mold thus had the shape and size of the surface of the patient's eardrum in the umbo area. Using the positive mold, the contact transducer assembly was constructed as follows.
- a very small drop of premixed Dow Corning Silastic silicone polymer medical grade MDX4-4210 (ten parts of base and one part of curing agent) was placed onto the umbo area of the positive mold to make a thin film in the umbo area.
- the silicone polymer may first be distributed around the circumference of the umbo area to form a dam defining the diameter of the final device, followed by filling the defined area with additional silicone polymer.
- the thin film forms the interface or membrane of the support means of the contact transducer assembly.
- the diameter of the resulting membrane varied between 4 and 6 millimeters and the thickness of the membrane was less than one millimeter.
- the surface of the membrane facing against the positive mold was of the configuration of the outer surface of the patient's eardrum in the umbo area.
- a magnet was utilized as the transducer 100.
- the magnet was a rare- earth-Samarium-Cobalt (SmCo) type having magnetic energy of 32 MGOe or higher and was frusto-conical having dimensions of approximately 2 mm large dia. by 1 mm small dia. by 1.5 mm high.
- the magnet was purchased from Seiko Instrument in Sendai, Japan.
- the magnet was electroplated with two layers of nickel and one layer of gold. The thickness of both layers of nickel was about 50 micrometers and the thickness of the gold layer was about 5 micrometers.
- the gold plated magnet was then coated with the same silicone polymer as was used to form the membrane. This was done by rotating the magnet in a small puddle of the silicone material. The coating was less than one millimeter thick and formed the housing for the magnet.
- the coated magnet was then placed onto the membrane formed on the positive mold.
- the entire assembly of positive mold, silicone polymer membrane, and silicone polymer coated magnet was placed in a preheated oven at 100°C for 15 minutes. After oven curing, the housing bonded to the membrane, thus supporting the magnet in the assembly.
- the coated magnet and membrane assembly was then removed from the positive mold using surgical instruments.
- the resulting contact transducer assembly was disinfected using isopropyl alcohol and was then slightly lubricated with mineral oil.
- Shipment of the device may be accomplished by placing the contact transducer assembly back onto the positive mold in a suitable package. Placement of the contact transducer assembly on the patient's eardrum was accomplished by a medical doctor using a non-magnetic instrument while using a microscope. The patient experienced no discomfort on placement and after wearing the device for an extended period of time. The patient was able to hear normally and at the same time was able to receive audio information transmitted as described above to the contact transducer assembly in a clear and unobtrusive
- EXAMPLE 2 A positive mold was produced from a negative eardrum impression as described above in Example 1 using materials identical to those used for the negative impression. Instead of silicone elastomer for the membrane a polymer was prepared using the following components. Three predistilled and refrigerated monomers were mixed at the following weight ratio: methylmethacrylate (50%), hexafluoroisopropyl methacrylate (25%) and tris-(trimethylsiloxy)-3 methacryloxypropylsilane (25%). The initiator AIBN, azo-bis(isobutyl) nitrile was added at the 0.2% weight level to the mixed monomers to initiate polymerization. Nitrogen was provided as a purge gas for the monomer mixture prior to polymerization. Polymerization was carried out at 75°C for 22 hours. The polymerization was followed by curing at the same temperature for an additional 17 hours. Following polymerization, the polymer was dissolved in ethyl acetate at a concentration of 10% by weight.
- the magnet was as described in Example 1 and was electroplated with two layers of nickel and a final layer of gold.
- the thickness of both layers of nickel was about 50 mircometers and the thickness of the gold layer was about 5 micrometers.
- a small drop of the polymer solution was placed onto the umbo area of the positive mold to produce the interface or membrane of the support structure. Placement was accomplished using a dropper and placing one drop at a time, waiting between drops until the previous drop became semi dry or sticky.
- the final diameter of the membrane was between four and six mm.
- the gold plated magnet was placed onto the center of the umbo area and two more smaller drops of polymer solution were applied to coat the magnet and thus form the housing.
- the surface of the membrane opposite the magnet and adjacent the positive mold conformed to the shape of the patient's eardrum in the umbo area.
- the contact transducer assembly while on the positive mold, was then air dried. After drying, the contact transducer assembly was carefully removed from the positive mold using surgical instruments. Transport and packaging of the contact transducer assembly may be accomplished as in Example 1 using the positive mold as a support.
- a hearing system according to the current invention may be used by hearing impaired persons, or by persons with normal hearing who want to receive audio information selectively.
- an individual who might want to receive a foreign language translation could temporarily use a signal producing means and an appropriate contact transducer means pre-set to impart the appropriate language to the individual.
- Other applications can involve systems in which an individual might want to receive certain direct information to the exclusion of others. Examples of the latter situations include sports events, public fora, simultaneous broadcasts of radio or television programs, etc.
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019930701355A KR100229086B1 (en) | 1990-11-07 | 1991-10-07 | Contact transducer assembly for hearing devices |
JP4501282A JPH06501599A (en) | 1990-11-07 | 1991-11-07 | Contact transducer assembly for hearing devices |
DE69121725T DE69121725T2 (en) | 1990-11-07 | 1991-11-07 | CONTACT TRANSMITTER FOR HEARING AID |
EP92900360A EP0556300B1 (en) | 1990-11-07 | 1991-11-07 | Contact transducer assembly for hearing devices |
BR919107069A BR9107069A (en) | 1990-11-07 | 1991-11-07 | AUDITION SYSTEM, PROCESS TO COMMUNICATE AUDIO INFORMATION TO AN INDIVIDUAL AND CONTACT TRANSDUCER SET FOR AN AUDITION SYSTEM |
AU90352/91A AU651642B2 (en) | 1990-11-07 | 1991-11-07 | Contact transducer assembly for hearing devices |
NO931628A NO931628D0 (en) | 1990-11-07 | 1993-05-05 | CONTACT FORMS FOR HEARING DEVICE |
FI932056A FI932056A0 (en) | 1990-11-07 | 1993-05-06 | KONTAKTOMVANDLARHOPSAETTNING FOER HOERAPPARATER |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61027490A | 1990-11-07 | 1990-11-07 | |
US610,274 | 1990-11-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992009181A1 true WO1992009181A1 (en) | 1992-05-29 |
Family
ID=24444387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1991/008333 WO1992009181A1 (en) | 1990-11-07 | 1991-11-07 | Contact transducer assembly for hearing devices |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0556300B1 (en) |
JP (1) | JPH06501599A (en) |
KR (1) | KR100229086B1 (en) |
AT (1) | ATE142072T1 (en) |
AU (1) | AU651642B2 (en) |
BR (1) | BR9107069A (en) |
CA (1) | CA2095432A1 (en) |
DE (1) | DE69121725T2 (en) |
DK (1) | DK0556300T3 (en) |
ES (1) | ES2092088T3 (en) |
FI (1) | FI932056A0 (en) |
HU (1) | HU9301331D0 (en) |
NO (1) | NO931628D0 (en) |
WO (1) | WO1992009181A1 (en) |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007343A1 (en) * | 1992-09-21 | 1994-03-31 | Gn Danavox A/S | Method for the securing of an electro-acoustic device on or in the human ear and electro-acoustic device for use in the method |
US5814095A (en) * | 1996-09-18 | 1998-09-29 | Implex Gmbh Spezialhorgerate | Implantable microphone and implantable hearing aids utilizing same |
EP1054573A2 (en) * | 1999-05-21 | 2000-11-22 | IMPLEX Aktiengesellschaft Hearing Technology | Device for mechanical coupling of a electromechanical hearing aid transducer implantable in a cavity in the mastoid |
KR100573622B1 (en) * | 2002-12-13 | 2006-04-25 | 주식회사 뉴로바이오시스 | Cochlea implant system in infrared communication type |
KR100977525B1 (en) | 2008-04-11 | 2010-08-23 | 주식회사 뉴로바이오시스 | A cochlea implant system in ITE in the ear type using infrared communication |
US8401214B2 (en) | 2009-06-18 | 2013-03-19 | Earlens Corporation | Eardrum implantable devices for hearing systems and methods |
US8715154B2 (en) | 2009-06-24 | 2014-05-06 | Earlens Corporation | Optically coupled cochlear actuator systems and methods |
US8715153B2 (en) | 2009-06-22 | 2014-05-06 | Earlens Corporation | Optically coupled bone conduction systems and methods |
US8845705B2 (en) | 2009-06-24 | 2014-09-30 | Earlens Corporation | Optical cochlear stimulation devices and methods |
US9055379B2 (en) | 2009-06-05 | 2015-06-09 | Earlens Corporation | Optically coupled acoustic middle ear implant systems and methods |
US9544700B2 (en) | 2009-06-15 | 2017-01-10 | Earlens Corporation | Optically coupled active ossicular replacement prosthesis |
US9749758B2 (en) | 2008-09-22 | 2017-08-29 | Earlens Corporation | Devices and methods for hearing |
US9924276B2 (en) | 2014-11-26 | 2018-03-20 | Earlens Corporation | Adjustable venting for hearing instruments |
US9930458B2 (en) | 2014-07-14 | 2018-03-27 | Earlens Corporation | Sliding bias and peak limiting for optical hearing devices |
US9949039B2 (en) | 2005-05-03 | 2018-04-17 | Earlens Corporation | Hearing system having improved high frequency response |
US9961454B2 (en) | 2008-06-17 | 2018-05-01 | Earlens Corporation | Optical electro-mechanical hearing devices with separate power and signal components |
US10034103B2 (en) | 2014-03-18 | 2018-07-24 | Earlens Corporation | High fidelity and reduced feedback contact hearing apparatus and methods |
US10154352B2 (en) | 2007-10-12 | 2018-12-11 | Earlens Corporation | Multifunction system and method for integrated hearing and communication with noise cancellation and feedback management |
US10178483B2 (en) | 2015-12-30 | 2019-01-08 | Earlens Corporation | Light based hearing systems, apparatus, and methods |
US10284964B2 (en) | 2010-12-20 | 2019-05-07 | Earlens Corporation | Anatomically customized ear canal hearing apparatus |
US10286215B2 (en) | 2009-06-18 | 2019-05-14 | Earlens Corporation | Optically coupled cochlear implant systems and methods |
US10292601B2 (en) | 2015-10-02 | 2019-05-21 | Earlens Corporation | Wearable customized ear canal apparatus |
US10492010B2 (en) | 2015-12-30 | 2019-11-26 | Earlens Corporations | Damping in contact hearing systems |
US10555100B2 (en) | 2009-06-22 | 2020-02-04 | Earlens Corporation | Round window coupled hearing systems and methods |
US11102594B2 (en) | 2016-09-09 | 2021-08-24 | Earlens Corporation | Contact hearing systems, apparatus and methods |
US11166114B2 (en) | 2016-11-15 | 2021-11-02 | Earlens Corporation | Impression procedure |
US11212626B2 (en) | 2018-04-09 | 2021-12-28 | Earlens Corporation | Dynamic filter |
US11350226B2 (en) | 2015-12-30 | 2022-05-31 | Earlens Corporation | Charging protocol for rechargeable hearing systems |
US11516603B2 (en) | 2018-03-07 | 2022-11-29 | Earlens Corporation | Contact hearing device and retention structure materials |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3548805B2 (en) * | 2002-07-24 | 2004-07-28 | 東北大学長 | Hearing aid system and hearing aid method |
US7421087B2 (en) * | 2004-07-28 | 2008-09-02 | Earlens Corporation | Transducer for electromagnetic hearing devices |
KR102170372B1 (en) | 2019-08-13 | 2020-10-27 | 주식회사 세이포드 | Sound anchor for transmitting sound to human tissues in the ear canal and semi-implantable hearing aid having the same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4776322A (en) * | 1985-05-22 | 1988-10-11 | Xomed, Inc. | Implantable electromagnetic middle-ear bone-conduction hearing aid device |
US4936305A (en) * | 1988-07-20 | 1990-06-26 | Richards Medical Company | Shielded magnetic assembly for use with a hearing aid |
US4944301A (en) * | 1988-06-16 | 1990-07-31 | Cochlear Corporation | Method for determining absolute current density through an implanted electrode |
US5003608A (en) * | 1989-09-22 | 1991-03-26 | Resound Corporation | Apparatus and method for manipulating devices in orifices |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2044870C3 (en) * | 1970-09-10 | 1978-12-21 | Dietrich Prof. Dr.Med. 7400 Tuebingen Plester | Hearing aid arrangement for the inductive transmission of acoustic signals |
US4817607A (en) * | 1986-03-07 | 1989-04-04 | Richards Medical Company | Magnetic ossicular replacement prosthesis |
-
1991
- 1991-10-07 KR KR1019930701355A patent/KR100229086B1/en not_active IP Right Cessation
- 1991-11-07 BR BR919107069A patent/BR9107069A/en unknown
- 1991-11-07 DK DK92900360.6T patent/DK0556300T3/da active
- 1991-11-07 WO PCT/US1991/008333 patent/WO1992009181A1/en active IP Right Grant
- 1991-11-07 AU AU90352/91A patent/AU651642B2/en not_active Ceased
- 1991-11-07 AT AT92900360T patent/ATE142072T1/en not_active IP Right Cessation
- 1991-11-07 EP EP92900360A patent/EP0556300B1/en not_active Expired - Lifetime
- 1991-11-07 HU HU931331A patent/HU9301331D0/en unknown
- 1991-11-07 JP JP4501282A patent/JPH06501599A/en active Pending
- 1991-11-07 ES ES92900360T patent/ES2092088T3/en not_active Expired - Lifetime
- 1991-11-07 DE DE69121725T patent/DE69121725T2/en not_active Expired - Fee Related
- 1991-11-07 CA CA002095432A patent/CA2095432A1/en not_active Abandoned
-
1993
- 1993-05-05 NO NO931628A patent/NO931628D0/en unknown
- 1993-05-06 FI FI932056A patent/FI932056A0/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4776322A (en) * | 1985-05-22 | 1988-10-11 | Xomed, Inc. | Implantable electromagnetic middle-ear bone-conduction hearing aid device |
US4944301A (en) * | 1988-06-16 | 1990-07-31 | Cochlear Corporation | Method for determining absolute current density through an implanted electrode |
US4936305A (en) * | 1988-07-20 | 1990-06-26 | Richards Medical Company | Shielded magnetic assembly for use with a hearing aid |
US5003608A (en) * | 1989-09-22 | 1991-03-26 | Resound Corporation | Apparatus and method for manipulating devices in orifices |
Cited By (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007343A1 (en) * | 1992-09-21 | 1994-03-31 | Gn Danavox A/S | Method for the securing of an electro-acoustic device on or in the human ear and electro-acoustic device for use in the method |
US5814095A (en) * | 1996-09-18 | 1998-09-29 | Implex Gmbh Spezialhorgerate | Implantable microphone and implantable hearing aids utilizing same |
EP1054573A2 (en) * | 1999-05-21 | 2000-11-22 | IMPLEX Aktiengesellschaft Hearing Technology | Device for mechanical coupling of a electromechanical hearing aid transducer implantable in a cavity in the mastoid |
EP1054573A3 (en) * | 1999-05-21 | 2006-01-04 | Phonak Ag | Device for mechanical coupling of a electromechanical hearing aid transducer implantable in a cavity in the mastoid |
KR100573622B1 (en) * | 2002-12-13 | 2006-04-25 | 주식회사 뉴로바이오시스 | Cochlea implant system in infrared communication type |
US9949039B2 (en) | 2005-05-03 | 2018-04-17 | Earlens Corporation | Hearing system having improved high frequency response |
US10863286B2 (en) | 2007-10-12 | 2020-12-08 | Earlens Corporation | Multifunction system and method for integrated hearing and communication with noise cancellation and feedback management |
US10516950B2 (en) | 2007-10-12 | 2019-12-24 | Earlens Corporation | Multifunction system and method for integrated hearing and communication with noise cancellation and feedback management |
US11483665B2 (en) | 2007-10-12 | 2022-10-25 | Earlens Corporation | Multifunction system and method for integrated hearing and communication with noise cancellation and feedback management |
US10154352B2 (en) | 2007-10-12 | 2018-12-11 | Earlens Corporation | Multifunction system and method for integrated hearing and communication with noise cancellation and feedback management |
KR100977525B1 (en) | 2008-04-11 | 2010-08-23 | 주식회사 뉴로바이오시스 | A cochlea implant system in ITE in the ear type using infrared communication |
US11310605B2 (en) | 2008-06-17 | 2022-04-19 | Earlens Corporation | Optical electro-mechanical hearing devices with separate power and signal components |
US10516949B2 (en) | 2008-06-17 | 2019-12-24 | Earlens Corporation | Optical electro-mechanical hearing devices with separate power and signal components |
US9961454B2 (en) | 2008-06-17 | 2018-05-01 | Earlens Corporation | Optical electro-mechanical hearing devices with separate power and signal components |
US10511913B2 (en) | 2008-09-22 | 2019-12-17 | Earlens Corporation | Devices and methods for hearing |
US11057714B2 (en) | 2008-09-22 | 2021-07-06 | Earlens Corporation | Devices and methods for hearing |
US9949035B2 (en) | 2008-09-22 | 2018-04-17 | Earlens Corporation | Transducer devices and methods for hearing |
US10743110B2 (en) | 2008-09-22 | 2020-08-11 | Earlens Corporation | Devices and methods for hearing |
US9749758B2 (en) | 2008-09-22 | 2017-08-29 | Earlens Corporation | Devices and methods for hearing |
US10237663B2 (en) | 2008-09-22 | 2019-03-19 | Earlens Corporation | Devices and methods for hearing |
US10516946B2 (en) | 2008-09-22 | 2019-12-24 | Earlens Corporation | Devices and methods for hearing |
US9055379B2 (en) | 2009-06-05 | 2015-06-09 | Earlens Corporation | Optically coupled acoustic middle ear implant systems and methods |
US9544700B2 (en) | 2009-06-15 | 2017-01-10 | Earlens Corporation | Optically coupled active ossicular replacement prosthesis |
US8787609B2 (en) | 2009-06-18 | 2014-07-22 | Earlens Corporation | Eardrum implantable devices for hearing systems and methods |
US8401214B2 (en) | 2009-06-18 | 2013-03-19 | Earlens Corporation | Eardrum implantable devices for hearing systems and methods |
US9277335B2 (en) | 2009-06-18 | 2016-03-01 | Earlens Corporation | Eardrum implantable devices for hearing systems and methods |
US10286215B2 (en) | 2009-06-18 | 2019-05-14 | Earlens Corporation | Optically coupled cochlear implant systems and methods |
US10555100B2 (en) | 2009-06-22 | 2020-02-04 | Earlens Corporation | Round window coupled hearing systems and methods |
US8715153B2 (en) | 2009-06-22 | 2014-05-06 | Earlens Corporation | Optically coupled bone conduction systems and methods |
US11323829B2 (en) | 2009-06-22 | 2022-05-03 | Earlens Corporation | Round window coupled hearing systems and methods |
US8715154B2 (en) | 2009-06-24 | 2014-05-06 | Earlens Corporation | Optically coupled cochlear actuator systems and methods |
US8845705B2 (en) | 2009-06-24 | 2014-09-30 | Earlens Corporation | Optical cochlear stimulation devices and methods |
US8986187B2 (en) | 2009-06-24 | 2015-03-24 | Earlens Corporation | Optically coupled cochlear actuator systems and methods |
US10284964B2 (en) | 2010-12-20 | 2019-05-07 | Earlens Corporation | Anatomically customized ear canal hearing apparatus |
US11153697B2 (en) | 2010-12-20 | 2021-10-19 | Earlens Corporation | Anatomically customized ear canal hearing apparatus |
US11743663B2 (en) | 2010-12-20 | 2023-08-29 | Earlens Corporation | Anatomically customized ear canal hearing apparatus |
US10609492B2 (en) | 2010-12-20 | 2020-03-31 | Earlens Corporation | Anatomically customized ear canal hearing apparatus |
US10034103B2 (en) | 2014-03-18 | 2018-07-24 | Earlens Corporation | High fidelity and reduced feedback contact hearing apparatus and methods |
US11317224B2 (en) | 2014-03-18 | 2022-04-26 | Earlens Corporation | High fidelity and reduced feedback contact hearing apparatus and methods |
US10531206B2 (en) | 2014-07-14 | 2020-01-07 | Earlens Corporation | Sliding bias and peak limiting for optical hearing devices |
US9930458B2 (en) | 2014-07-14 | 2018-03-27 | Earlens Corporation | Sliding bias and peak limiting for optical hearing devices |
US11800303B2 (en) | 2014-07-14 | 2023-10-24 | Earlens Corporation | Sliding bias and peak limiting for optical hearing devices |
US11259129B2 (en) | 2014-07-14 | 2022-02-22 | Earlens Corporation | Sliding bias and peak limiting for optical hearing devices |
US10516951B2 (en) | 2014-11-26 | 2019-12-24 | Earlens Corporation | Adjustable venting for hearing instruments |
US11252516B2 (en) | 2014-11-26 | 2022-02-15 | Earlens Corporation | Adjustable venting for hearing instruments |
US9924276B2 (en) | 2014-11-26 | 2018-03-20 | Earlens Corporation | Adjustable venting for hearing instruments |
US10292601B2 (en) | 2015-10-02 | 2019-05-21 | Earlens Corporation | Wearable customized ear canal apparatus |
US11058305B2 (en) | 2015-10-02 | 2021-07-13 | Earlens Corporation | Wearable customized ear canal apparatus |
US10306381B2 (en) | 2015-12-30 | 2019-05-28 | Earlens Corporation | Charging protocol for rechargable hearing systems |
US11516602B2 (en) | 2015-12-30 | 2022-11-29 | Earlens Corporation | Damping in contact hearing systems |
US10779094B2 (en) | 2015-12-30 | 2020-09-15 | Earlens Corporation | Damping in contact hearing systems |
US10492010B2 (en) | 2015-12-30 | 2019-11-26 | Earlens Corporations | Damping in contact hearing systems |
US11070927B2 (en) | 2015-12-30 | 2021-07-20 | Earlens Corporation | Damping in contact hearing systems |
US11337012B2 (en) | 2015-12-30 | 2022-05-17 | Earlens Corporation | Battery coating for rechargable hearing systems |
US11350226B2 (en) | 2015-12-30 | 2022-05-31 | Earlens Corporation | Charging protocol for rechargeable hearing systems |
US10178483B2 (en) | 2015-12-30 | 2019-01-08 | Earlens Corporation | Light based hearing systems, apparatus, and methods |
US11540065B2 (en) | 2016-09-09 | 2022-12-27 | Earlens Corporation | Contact hearing systems, apparatus and methods |
US11102594B2 (en) | 2016-09-09 | 2021-08-24 | Earlens Corporation | Contact hearing systems, apparatus and methods |
US11671774B2 (en) | 2016-11-15 | 2023-06-06 | Earlens Corporation | Impression procedure |
US11166114B2 (en) | 2016-11-15 | 2021-11-02 | Earlens Corporation | Impression procedure |
US11516603B2 (en) | 2018-03-07 | 2022-11-29 | Earlens Corporation | Contact hearing device and retention structure materials |
US11212626B2 (en) | 2018-04-09 | 2021-12-28 | Earlens Corporation | Dynamic filter |
US11564044B2 (en) | 2018-04-09 | 2023-01-24 | Earlens Corporation | Dynamic filter |
Also Published As
Publication number | Publication date |
---|---|
EP0556300A1 (en) | 1993-08-25 |
DE69121725D1 (en) | 1996-10-02 |
DE69121725T2 (en) | 1997-02-13 |
KR100229086B1 (en) | 1999-11-01 |
ES2092088T3 (en) | 1996-11-16 |
AU651642B2 (en) | 1994-07-28 |
AU9035291A (en) | 1992-06-11 |
NO931628D0 (en) | 1993-05-05 |
FI932056A0 (en) | 1993-05-06 |
BR9107069A (en) | 1993-09-28 |
DK0556300T3 (en) | 1997-02-10 |
EP0556300B1 (en) | 1996-08-28 |
JPH06501599A (en) | 1994-02-17 |
ATE142072T1 (en) | 1996-09-15 |
HU9301331D0 (en) | 1993-09-28 |
CA2095432A1 (en) | 1992-05-08 |
EP0556300A4 (en) | 1993-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU651642B2 (en) | Contact transducer assembly for hearing devices | |
US5259032A (en) | contact transducer assembly for hearing devices | |
US5220918A (en) | Trans-tympanic connector for magnetic induction hearing aid | |
AU606588B2 (en) | Magnetic induction hearing aid | |
US8568291B2 (en) | Bone conductive devices for improving hearing | |
US6190305B1 (en) | Implantable and external hearing systems having a floating mass transducer | |
US11012797B2 (en) | Bone conduction device having magnets integrated with housing | |
US5624376A (en) | Implantable and external hearing systems having a floating mass transducer | |
KR100282067B1 (en) | Transducer of Middle Ear Implant Hearing Aid | |
US6171229B1 (en) | Ossicular transducer attachment for an implantable hearing device | |
US4988333A (en) | Implantable middle ear hearing aid system and acoustic coupler therefor | |
US5456654A (en) | Implantable magnetic hearing aid transducer | |
US7955249B2 (en) | Output transducers for hearing systems | |
Hamanishi et al. | A new electromagnetic hearing aid using lightweight coils to vibrate the ossicles | |
AU632510B2 (en) | Trans-tympanic connector for magnetic induction hearing aid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BB BG BR CA FI HU JP KP KR LK MC MG MW NO PL RO SD SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU ML MR NL SE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2095432 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992900360 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 932056 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1992900360 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1992900360 Country of ref document: EP |